LEADER 03537nam 2200649Ia 450 001 9910457252903321 005 20200520144314.0 010 $a1-281-11983-0 010 $a9786611119836 010 $a0-08-054824-5 035 $a(CKB)1000000000357843 035 $a(EBL)305505 035 $a(OCoLC)162131368 035 $a(SSID)ssj0000098016 035 $a(PQKBManifestationID)11543273 035 $a(PQKBTitleCode)TC0000098016 035 $a(PQKBWorkID)10121606 035 $a(PQKB)10688063 035 $a(MiAaPQ)EBC305505 035 $a(Au-PeEL)EBL305505 035 $a(CaPaEBR)ebr10188620 035 $a(CaONFJC)MIL111983 035 $a(EXLCZ)991000000000357843 100 $a19930716d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAdvances in antiviral drug design$hVolume 5$b[electronic resource] /$feditor, E. De Clercq 210 $aGreenwich, CT ;$aLondon, England $cJai Press$d2007 215 $a1 online resource (265 p.) 225 0 $aAdvances in antiviral drug design ;$v5 300 $aDescription based upon print version of record. 311 $a0-444-52173-9 320 $aIncludes bibliographical references and index. 327 $aI. IntroductionII. Design; III. Synthesis; IV. Antiviral activity; Acknowledgements; References; Chapter 4. Synthesis and antiviral evaluation of broad spectrum, orally active analogs of cidofovir and other acyclic nucleoside phosphonates; I. Introduction; II. Synthesis of hexadecyloxypropyl and related esters of cidofovir; III. Antiviral evaluation and spectrum of activity; IV. Structure activity relationships; V. Cellular metabolism; VI. Oral pharmacokinetics and tissue distribution; VII. Antiviral activity in animal models of viral diseases 327 $aVIII. Alkoxyalkyl esters of (S)-HPMPA and other acyclic nucleoside phosphonatesIX. Conclusions; Acknowledgements; References; Chapter 5. CCR5 antagonistsCCR5 antagonists for the treatment ofHIV infection and AIDS; I. Introduction; II. Inhibition of HIV entry; III. CCR5 as a drug target; IV. The discovery of novel CCR5 antagonists; V. Molecular mechanisms; VI. Resistance to CCR5 antagonists in vitro and in the clinic; VII. Conclusions; References; Chapter 6. The medicinal chemistry of the DATADATA and DAPYDAPY series of HIV-1HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIsNNRTIs) 327 $aAbstractI. Introduction; II. The diaryltriazine (DATA) series; III. The diarylpyrimidine (DAPY) series; IV. Conclusion; Acknowledgements; References; Index 330 $aRegularly reviewing the ""state-of-the-art"" developments in the antiviral drug research field, this latest volume spans the conceptual design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use. 410 0$aAdvances in Antiviral Drug Design 606 $aAntiviral agents 606 $aAnti-infective agents 608 $aElectronic books. 615 0$aAntiviral agents. 615 0$aAnti-infective agents. 676 $a616.9 676 $a616.9/25061/05 676 $a616.91061 701 $aDe Clercq$b Erik$066569 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457252903321 996 $aAdvances in antiviral drug design$92167216 997 $aUNINA LEADER 01420nam a2200241 a 4500 001 991000745009707536 008 100525s1707 it 000 0 ita 035 $ab13904826-39ule_inst 040 $aDip.to Studi Storici$bita 100 1 $aCervellino, Lorenzo$0174501 245 10$aDirezione, overo Guida dell'Universitą per la sua retta amministrazione in conformitą delle Regie Prammatiche, Decisioni della regia Camera della Summaria, Capitoli e Costituzioni del Regno ... /$cdel dottor Lorenzo Cervillini della Terra di Oppido Diocese d'Acerenza, e Matera ; con le annotazioni di Leonardo Ricci ... 260 $aNapoli :$bnella stamperia di Felice Mosca ; a spese di Francesco Antonio Perazzo,$c1707 300 $a234 p. ;$cfol. 500 $aStemma, iniziali e fregi xil. - Esempl. con rileg. moderna. 500 $aTesto su due colonne 500 $aImpronta: e'he i-e. n-o- o,i- (3) 1707 (R) 700 $aRicci, Leonardo$d<1640-1720> 907 $a.b13904826$b02-04-14$c25-05-10 912 $a991000745009707536 945 $aLE023 Ed. ant. XXI, 1$g1$lle023$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i15134726$z25-05-10 996 $aDirezione, overo Guida dell'Universitą per la sua retta amministrazione in conformitą delle Regie Prammatiche, Decisioni della regia Camera della Summaria, Capitoli e Costituzioni del Regno ..$9228052 997 $aUNISALENTO 998 $ale023$b25-05-10$cm$da $eo$fita$git $h0$i0 LEADER 02289nam 22005172 450 001 9910807960203321 005 20180129172945.0 010 $a1-4744-2053-2 010 $a1-4744-3564-5 010 $a1-4744-2052-4 024 7 $a10.1515/9781474420525 035 $a(CKB)4340000000196012 035 $a(StDuBDS)EDZ0001818430 035 $a(MiAaPQ)EBC5011044 035 $a(UkCbUP)CR9781474420525 035 $a(DE-B1597)614473 035 $a(DE-B1597)9781474420525 035 $a(OCoLC)1306542210 035 $a(EXLCZ)994340000000196012 100 $a20170811d2017|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aModern Arabic literature $ea theoretical framework /$fReuven Snir$b[electronic resource] 210 1$aEdinburgh :$cEdinburgh University Press,$d2017. 215 $a1 online resource (xii, 404 pages) $cdigital, PDF file(s) 300 $aTitle from publisher's bibliographic system (viewed on 25 Jan 2018). 311 $a1-4744-2051-6 320 $aIncludes bibliographical references and index. 327 $tFrontmatter -- $tContents -- $tPreface -- $tNotes on Transliteration -- $tIntroduction -- $tChapter 1 The Modern Arabic Literary System -- $tChapter 2 Literary Dynamics in Synchronic Cross-section -- $tChapter 3 Outlines of Diachronic Intersystemic Development -- $tChapter 4 Literary Dynamics in Generic and Diachronic Cross-section -- $tConclusion -- $tReferences -- $tIndex 330 $aThe study of Arabic literature is blossoming. This book provides a comprehensive theoretical framework to help research this highly prolific and diverse production of contemporary literary texts. 606 $aArabic literature$y20th century$xHistory and criticism 606 $aArabic literature$y21st century$xHistory and criticism 608 $aCriticism, interpretation, etc.$2fast 615 0$aArabic literature$xHistory and criticism. 615 0$aArabic literature$xHistory and criticism. 676 $a892.7/09007 700 $aSnir$b R$g(Reuven),$0908016 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910807960203321 996 $aModern Arabic literature$94027717 997 $aUNINA